PRR16/Largen Induces Epithelial-Mesenchymal Transition through the Interaction with ABI2 Leading to the Activation of ABL1 Kinase |
Kang, Gyeoung Jin
(Lillehei Heart Institute, University of Minnesota)
Park, Jung Ho (College of Pharmacy, Dongguk University) Kim, Hyun Ji (College of Pharmacy, Dongguk University) Kim, Eun Ji (Lillehei Heart Institute, University of Minnesota) Kim, Boram (College of Pharmacy, Dongguk University) Byun, Hyun Jung (College of Pharmacy, Dongguk University) Yu, Lu (College of Pharmacy, Dongguk University) Nguyen, Tuan Minh (College of Pharmacy, Dongguk University) Nguyen, Thi Ha (College of Pharmacy, Dongguk University) Kim, Kyung Sung (College of Pharmacy, Dongguk University) Huy, Hieu Phung (College of Pharmacy, Dongguk University) Rahman, Mostafizur (College of Pharmacy, Dongguk University) Kim, Ye Hyeon (College of Pharmacy, Dongguk University) Jang, Ji Yun (College of Pharmacy, Dongguk University) Park, Mi Kyung (National Cancer Center) Lee, Ho (National Cancer Center) Choi, Chang Ick (College of Pharmacy, Dongguk University) Lee, Kyeong (College of Pharmacy, Dongguk University) Han, Hyo Kyung (College of Pharmacy, Dongguk University) Cho, Jungsook (College of Pharmacy, Dongguk University) Rho, Seung Bae (National Cancer Center) Lee, Chang Hoon (College of Pharmacy, Dongguk University) |
1 | Allington, T. M., Galliher-Beckley, A. J. and Schiemann, W. P. (2009) Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors. FASEB J. 23, 4231-4243. DOI |
2 | Brabletz, T., Kalluri, R., Nieto, M. A. and Weinberg, R. A. (2018) EMT in cancer. Nat. Rev. Cancer 18, 128-134. DOI |
3 | Gu, J. J., Rouse, C., Xu, X., Wang, J., Onaitis, M. W. and Pendergast, A. M. (2016) Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis. JCI insight 1, e89647. |
4 | Guo, S. and Deng, C. X. (2018) Effect of stromal cells in tumor microenvironment on metastasis initiation. Int. J. Biol. Sci. 14, 2083-2093. DOI |
5 | Jain, A., Tripathi, R., Turpin, C. P., Wang, C. and Plattner, R. (2017) Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma. Oncogene 36, 4585-4596. DOI |
6 | Jones, S. E. (2008) Metastatic breast cancer: the treatment challenge. Clin. Breast Cancer 8, 224-233. DOI |
7 | Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O. and Gelmon, K. (2010) Metastatic behavior of breast cancer subtypes. J. Clin. Oncol. 28, 3271-3277. DOI |
8 | Huang, J., Qin, Y., Yang, C., Wan, C., Dai, X., Sun, Y., Meng, J., Lu, Y., Li, Y. and Zhang, Z. (2020) Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling. Aging (Albany N.Y.) 12, 340-358. DOI |
9 | Bai, K. H., He, S. Y., Shu, L. L., Wang, W. D., Lin, S. Y., Zhang, Q. Y., Li, L., Cheng, L. and Dai, Y. J. (2020) Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index. Cancer Med. 9, 4290-4298. DOI |
10 | Dai, Z. and Pendergast, A. M. (1995) Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9, 2569-2582. DOI |
11 | Kang, J. H., Kim, H. J., Park, M. K. and Lee, C. H. (2017) Sphingosylphosphorylcholine induces thrombospondin-1 secretion in MCF10A cells via ERK2. Biomol. Ther. (Seoul) 25, 625-633. DOI |
12 | Rho, S. B., Byun, H. J., Kim, B. R. and Lee, C. H. (2021a) Knockdown of LKB1 sensitizes endometrial cancer cells via AMPK activation. Biomol. Ther. (Seoul) 29, 650-657. DOI |
13 | Persaud, A., Alberts, P., Amsen, E. M., Xiong, X., Wasmuth, J., Saadon, Z., Fladd, C., Parkinson, J. and Rotin, D. (2009) Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays. Mol. Syst. Biol. 5, 333. DOI |
14 | Suh, Y., Yoon, C., Kim, R., Lim, E., Oh, Y., Hwang, S., An, S., Yoon, G., Gye, M., Yi, J., Kim, M. J. and Lee, S. J. (2013) Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 32, 4873-4882. DOI |
15 | Wang, J., Rouse, C., Jasper, J. S. and Pendergast, A. M. (2016) ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling. Sci. Signal. 9, ra12. DOI |
16 | Xu, X., Zhang, M., Xu, F. and Jiang, S. (2020) Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol. Cancer 19, 165. DOI |
17 | Yamamoto, K., Gandin, V., Sasaki, M., McCracken, S., Li, W., Silvester, J. L., Elia, A. J., Wang, F., Wakutani, Y., Alexandrova, R., Oo, Y. D., Mullen, P. J., Inoue, S., Itsumi, M., Lapin, V., Haight, J., Wakeham, A., Shahinian, A., Ikura, M., Topisirovic, I., Sonenberg, N. and Mak, T. W. (2014) Largen: a molecular regulator of mammalian cell size control. Mol. Cell 53, 904-915. DOI |
18 | Snezhkina, A., Lukyanova, E., Fedorova, M., Kalinin, D., Melnikova, N., Stepanov, O., Kiseleva, M., Kaprin, A., Pudova, E. and Kudryavtseva, A. (2019) Novel genes associated with the development of carotid Paragangliomas. Mol. Biol. 53, 547-559. DOI |
19 | Zandy, N. L., Playford, M. and Pendergast, A. M. (2007) Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases. Proc. Natl. Acad. Sci. U.S.A. 104, 17686-17691. DOI |
20 | Lee, C. H. (2019) Reversal of epithelial-mesenchymal transition by natural anti-inflammatory and pro-resolving lipids. Cancers 11, 1841. DOI |
21 | Luck, K., Kim, D. K., Lambourne, L., Spirohn, K., Begg, B. E., Bian, W., Brignall, R., Cafarelli, T., Campos-Laborie, F. J., Charloteaux, B., Choi, D., Cote, A. G., Daley, M., Deimling, S., Desbuleux, A., Dricot, A., Gebbia, M., Hardy, M. F., Kishore, N., Knapp, J. J., Kovacs, I. A., Lemmens, I., Mee, M. W., Mellor, J. C., Pollis, C., Pons, C., Richardson, A. D., Schlabach, S., Teeking, B., Yadav, A., Babor, M., Balcha, D., Basha, O., Bowman-Colin, C., Chin, S. F., Choi, S. G., Colabella, C., Coppin, G., D'Amata, C., De Ridder, D., De Rouck, S., Duran-Frigola, M., Ennajdaoui, H., Goebels, F., Goehring, L., Gopal, A., Haddad, G., Hatchi, E., Helmy, M., Jacob, Y., Kassa, Y., Landini, S., Li, R., van Lieshout, N., MacWilliams, A., Markey, D., Paulson, J. N., Rangarajan, S., Rasla, J., Rayhan, A., Rolland, T., San-Miguel, A., Shen, Y., Sheykhkarimli, D., Sheynkman, G. M., Simonovsky, E., Tasan, M., Tejeda, A., Tropepe, V., Twizere, J. C., Wang, Y., Weatheritt, R. J., Weile, J., Xia, Y., Yang, X., Yeger-Lotem, E., Zhong, Q., Aloy, P., Bader, G. D., De Las Rivas, J., Gaudet, S., Hao, T., Rak, J., Tavernier, J., Hill, D. E., Vidal, M., Roth, F. P. and Calderwood, M. A. (2020) A reference map of the human binary protein interactome. Nature 580, 402-408. DOI |
22 | Zandy, N. L. and Pendergast, A. M. (2008) Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases. Cell Cycle 7, 444-448. DOI |
23 | Bryce, N. S., Reynolds, A. B., Koleske, A. J. and Weaver, A. M. (2013) WAVE2 regulates epithelial morphology and cadherin isoform switching through regulation of Twist and Abl. PLoS ONE 8, e64533. DOI |
24 | Rho, S. B., Lee, K. W., Lee, S. H., Byun, H. J., Kim, B. R. and Lee, C. H. (2021b) Novel anti-angiogenic and anti-tumour activities of the N-terminal domain of NOEY2 via binding to VEGFR-2 in ovarian cancer. Biomol. Ther. (Seoul) 29, 506-518. DOI |
25 | Rolland, T., Tasan, M., Charloteaux, B., Pevzner, S. J., Zhong, Q., Sahni, N., Yi, S., Lemmens, I., Fontanillo, C., Mosca, R., Kamburov, A., Ghiassian, S. D., Yang, X., Ghamsari, L., Balcha, D., Begg, B. E., Braun, P., Brehme, M., Broly, M. P., Carvunis, A. R., Convery-Zupan, D., Corominas, R., Coulombe-Huntington, J., Dann, E., Dreze, M., Dricot, A., Fan, C., Franzosa, E., Gebreab, F., Gutierrez, B. J., Hardy, M. F., Jin, M., Kang, S., Kiros, R., Lin, G. N., Luck, K., MacWilliams, A., Menche, J., Murray, R. R., Palagi, A., Poulin, M. M., Rambout, X., Rasla, J., Reichert, P., Romero, V., Ruyssinck, E., Sahalie, J. M., Scholz, A., Shah, A. A., Sharma, A., Shen, Y., Spirohn, K., Tam, S., Tejeda, A. O., Trigg, S. A., Twizere, J. C., Vega, K., Walsh, J., Cusick, M. E., Xia, Y., Barabasi, A. L., Iakoucheva, L. M., Aloy, P., De Las Rivas, J., Tavernier, J., Calderwood, M. A., Hill, D. E., Hao, T., Roth, F. P. and Vidal, M. (2014) A proteome-scale map of the human interactome network. Cell 159, 1212-1226. DOI |
26 | Lee, C. H. (2018) Epithelial-mesenchymal transition: initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids. Biochem. Pharmacol. 158, 261-273. DOI |
27 | Lei, Q. Y., Zhang, H., Zhao, B., Zha, Z. Y., Bai, F., Pei, X. H., Zhao, S., Xiong, Y. and Guan, K. L. (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28, 2426-2436. DOI |
28 | Lu, X. and Kang, Y. (2007) Organotropism of breast cancer metastasis. J. Mammary Gland Biol. Neoplasia 12, 153-162. DOI |
29 | Nam, M. W., Kim, C. W. and Choi, K. C. (2022) Epithelial-mesenchymal transition-inducing factors involved in the progression of lung cancers. Biomol. Ther. (Seoul) 30, 213-220. DOI |
30 | Peart, O. (2017) Metastatic breast cancer. Radiol. Technol. 88, 519M539M. |
31 | Wang, W., Li, M., Ponnusamy, S., Chi, Y., Xue, J., Fahmy, B., Fan, M., Miranda-Carboni, G. A., Narayanan, R., Wu, J. and Wu, Z. H. (2020) ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancers. Nat. Commun. 11, 3965. DOI |
![]() |